Skip to main content
Clinical Trials/DRKS00032683
DRKS00032683
Not Yet Recruiting
N/A

Development, implementation and evaluation of Educational tools and Decision Aids for immune checkpoint-inhibitors in advanced LUng cancer: a mixed-methods Study (DEDALUS) / Part I: Development - DEDALUS I

niversitätsklinikum Heidelberg Thoraxklinik Heidelberg0 sites20 target enrollmentSeptember 14, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
C34.9
Sponsor
niversitätsklinikum Heidelberg Thoraxklinik Heidelberg
Enrollment
20
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 14, 2023
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitätsklinikum Heidelberg Thoraxklinik Heidelberg

Eligibility Criteria

Inclusion Criteria

  • Stage IV lung cancer, before, under or after immunotherapy (immune checkpoint inhibitors)

Exclusion Criteria

  • inadequate knowledge of German, incapable of giving informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials